Arch Venture Partners Xii, Llc's Net Worth
Arch Venture Partners Xii, Llc's net worth is estimated to be at least $12,626,572.57 as of 08/17/2025. CoreStreet's estimation of Arch Venture Partners Xii, Llc's net worth is based on their sale of stock and current holding of stock.
Arch Venture Partners Xii, Llc is Major Shareholder at Prime Medicine, Inc. Common Stock. They have executed at least 8 trades of stock as per SEC Form 4 filings. Their most recent trade was for 3,030,300 units of PRME stock on 08/01/2025. Their biggest sale was on when they sold units of stock for $. They typically trade 4 times per year.
Total value of insider buys:
- $12,626,572.57
Total value of insider sells:
- $0.00
Most recent insider trade:
- Aug. 1, 2025
Arch Venture Partners Xii, Llc's Insider Trading History
| Prime Medicine, Inc. Common Stock | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 1, 2025 | Major Shareholder | 3,030,300 | $3.30 | Buy | $9,999,990.00 |
| Neumora Therapeutics, Inc. Common Stock | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 14, 2023 | Major Shareholder | 3,357 | $11.98 | Buy | $40,216.86 |
Nov. 9, 2023 | Major Shareholder | 31,079 | $10.53 | Buy | $327,261.87 |
Nov. 7, 2023 | Major Shareholder | 30,192 | $11.50 | Buy | $347,208.00 |
Sept. 29, 2023 | Major Shareholder | 34,560 | $13.98 | Buy | $483,148.80 |
Sept. 27, 2023 | Major Shareholder | 24,504 | $12.31 | Buy | $301,644.24 |
Sept. 25, 2023 | Major Shareholder | 60,740 | $11.22 | Buy | $681,502.80 |
Sept. 22, 2023 | Major Shareholder | 40,000 | $11.14 | Buy | $445,600.00 |